|
MRK's Income from Cont. Operations Growth by Quarter and Year
Merck And Co Inc 's Income from Cont. Operations results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Income from Cont. Operations Growth Y/Y▼
|
Income from Cont. Operations Growth Y/Y▼
|
| MRK Income from Cont. Operations (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
3,387.00
|
-2,092.00
|
2,364.00
|
| III Quarter |
September |
-
|
4,571.00
|
2,945.00
|
1,907.00
|
| II Quarter |
June |
-
|
1,214.00
|
3,010.00
|
2,644.00
|
| I Quarter |
March |
4,313.00
|
3,186.00
|
3,219.00
|
2,862.00
|
| FY |
|
4,313.00
|
12,358.00
|
7,082.00
|
9,777.00
|
| MRK Income from Cont. Operations first quarter 2022 Y/Y Growth Comment |
Merck and Co Inc achieved in the first quarter 2022, above Company average Income from Cont. Operations growth of 35.37% year on year, to $ 4,313.00 millions.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Income from Cont. Operations growth. While Merck And Co Inc ' s Income from Cont. Operations rise of 35.37% ranks overall at the positon no. 714 in the first quarter 2022.
|
| MRK Income from Cont. Operations ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
32.96 % |
| III Quarter |
September |
- |
55.21 % |
54.43 % |
-2.6 % |
| II Quarter |
June |
- |
-59.67 % |
13.84 % |
54.08 % |
| I Quarter |
March |
35.37 % |
-1.03 % |
12.47 % |
286.23 % |
| FY |
|
- |
74.5 % |
-27.56 % |
57.87 % |
MRK Income from Cont. Operations (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-25.9 % |
- |
23.96 % |
| III Quarter |
September |
- |
276.52 % |
-2.16 % |
-27.87 % |
| II Quarter |
June |
- |
-61.9 % |
-6.49 % |
-7.62 % |
| I Quarter |
March |
27.34 % |
- |
36.17 % |
60.97 % |
| FY (Year on Year) |
|
- |
74.5 % |
-27.56 % |
57.87 % |
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 146.86 % |
7.94 % |
-87.73 % |
| (Sep 30 2018) |
|
(Dec. 30, 2010) |
|
|
| Income from Cont. Operations Y/Y Growth Statistics |
| High |
Average |
Low |
| 146.86 % |
7.94 % |
-87.73 % |
| (Sep 30 2018) |
|
(Dec. 30, 2010) |
|
| Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Income from Cont. Operations Growth
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 770.19 % |
29.37 % |
-94.94 % |
| IV. Quarter |
|
(March 31, 2010) |
| MRK's I. Quarter Q/Q Income from Cont. Operations Comment |
Merck and Co Inc achieved in the I. Quarter 2022 below company average Income from Cont. Operations jump of 27.34% quarter on quarter, to $ 4,313.00 millions.
Albeit the I. Quarter 2022 MRK's performance was beneath the average of 29.37 %, it has been yet good sign, as the I. Quarter surge, eclipses the % Income from Cont. Operations surge in the same quarter a year ago
Within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 526. |
|
|
|
| Income from Cont. Operations Q/Q Growth Statistics |
| High |
Average |
Low |
| 770.19 % |
29.37 % |
-94.94 % |
| IV. Quarter |
|
(March 31, 2010) |
| MRK's I. Quarter Q/Q Income from Cont. Operations Comment |
Merck and Co Inc achieved in the I. Quarter 2022 below company average Income from Cont. Operations jump of 27.34% quarter on quarter, to $ 4,313.00 millions.
I. Quarter 2022 Merck And Co Inc 's results appear to be paradoxical, even if lower than the average rise of 29.37 %, yet it presents real recovery compare to the % in the I. Quarter 2021 Melissa Hall, a business contributor situated in Chicago wrote.
Within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Merck And Co Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 526. |
|
Merck And Co Inc 's 12 Months Income from Cont. Operations Growth Year on Year
Income from Cont. Operations TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Income from Cont. Operations 12 Months Ending |
$ 13,485.00 |
$ 12,358.00 |
$ 6,879.00 |
$ 5,253.00 |
$ 7,049.00 |
| Y / Y Income from Cont. Operations Growth (TTM) |
91.3 % |
74.5 % |
-40.38 % |
-49.97 % |
-30.44 % |
| Year on Year Income from Cont. Operations Growth Overall
Ranking |
# 430 |
# 480 |
# 1101 |
# 1781 |
# 1073 |
| Seqeuential Income from Cont. Operations Change (TTM) |
9.12 % |
79.65 % |
30.95 % |
-25.48 % |
-0.47 % |
| Seq. Income from Cont. Operations Growth (TTM) Overall
Ranking |
# 714 |
# 155 |
# 245 |
# 2146 |
# 1115 |
| Cumulative Income from Cont. Operations growth
Comment |
Merck And Co Inc saw improvement in Income from Cont. Operations growth trend, posting cumulative 12 months Income from Cont. Operations growth of 91.3% year on year, to $ 13,485 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Income from Cont. Operations growth was higher than company's average 37% and higher than 74.5% growth in Dec 31 2021.
But from the previous reporting period rise was slower at 9.12 % from $12358 millions reported in twelve months ending a quarter Dec 31 2021 Melissa Hall continued.
Still this was confirmation of convincing trend, as the typical sequential Income from Cont. Operations gain stands at 7.94%.
The momentum is even more impressive sequentially clinched at 9.12 % increase from $12358 millions in twelve months ending a quarter before.
Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 430, from total ranking in previous quarter at 480. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
7.94 % |
-87.73 % |
|
|
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
37 % |
-92.46 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 22 |
| Sector |
# 57 |
| S&P 500 |
# 714 |
|
| Cumulative Income from Cont. Operations growth
Comment |
Merck And Co Inc saw improvement in Income from Cont. Operations growth trend, posting cumulative 12 months Income from Cont. Operations growth of 91.3% year on year, to $ 13,485 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Income from Cont. Operations growth was higher than company's average 37% and higher than 74.5% growth in Dec 31 2021.
But sequential growth rate was slower at 9.12 % from $12358 millions recorded in twelve months ending a quarter before.
In spite of, it was validation of positive momentum, as the typical Q/Q TTM Income from Cont. Operations advancement lays at 7.94%.
The growth was even more impressive from the previous reporting period clinched at 9.12 % jump from $12358 millions in twelve months ending a quarter Dec 31 2021.
Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 430, from total ranking in previous quarter at 480. |
| Income from Cont. Operations TTM Q/Q Growth Statistics |
| High |
Average |
Low |
146.86 % |
7.94 % |
-87.73 % |
|
|
|
| Income from Cont. Operations TTM Y/Y Growth Statistics |
| High |
Average |
Low |
575.58 % |
37 % |
-92.46 % |
|
|
|
| Income from Cont. Operations TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 22 |
| Sector |
# 57 |
| S&P 500 |
# 714 |
|
59.47%